[{"from": "human", "value": "Provide a brief overview of this molecule. [C][O][C][=C][C][=Branch2][Branch1][=Branch1][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][/C][=C][Branch2][Ring2][Ring2][\\C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][C][C][C][=Branch1][C][=O][N][C][=Branch1][C][=O][S][Ring1][#Branch1][/C][=Branch1][C][=O][O][C][O][C]"}, {"from": "gpt", "value": "The molecule is investigated for use/treatment in diabetes mellitus type 2. CLX-0921 is a solid. CLX-0921 has a spectrum of activity that differs from commercially available thiazolidinediones. This substance targets the protein peroxisome proliferator-activated receptor gamma. It is a pharmacologically active antihyperglycemic agent that acts by increasing peripheral tissue sensitivity to insulin."}]